Navigation Links
Man against HIV – new vaccine ready for human trials

A new vaccine called the TAT vaccine has been developed in Italy as the latest and most exciting HIV vaccine to date. And more importantly it has had a 71% success rate when tested on monkeys. This vaccine is now ready for human testing and this may be the brightest hope for mankind against the destructive HIV.

Dr.Barbara Ensoli, Head of the Department of Virology at Italy’s National Health Institute and Dr.Robert Gallo, one of the fathers of AIDS research have developed this vaccine which promises to be a strong salvo against the human immunodeficiency virus.

This project has consumed five years of dedicated work and employs an entirely new approach in tackling the virus. The idea is to block the virus from growing inside the body rather than trying to bolster the immune system against the virus as many vaccines try to do.

TAT protein is an important protein in the virus, which is a key building block of the dreaded virus. By blocking the TAT protein the scientists hope to stop the growth of the virus inside the human body. So they say this vaccine will be effective even in old cases of HIV. All eyes are now on the results of human testing of this vaccine to see how effective this could be.

The ability of the virus to mutate and survive has made it smart and strong to survive all the initiatives man has taken to eliminate it. The TAT vaccine is the latest hope for man against the virus! Lets hope this works!!
'"/>




Page: 1

Related medicine news :

1. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
2. Antibiotics losing their power against acne
3. South Africa Wins landmark case against pharmaceutical giants
4. Vitamin E, the latest warrior against diabetes
5. Acne may protect against infections
6. Fight against E.coli
7. Defence against free radicals
8. Progestin protects against ovarian cancer
9. Beverage protect against bladder cancer
10. Moderate alcohol consumption protects against dementia
11. Broccolis role against cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: